市場調査レポート
商品コード
1363515
低用量非経口薬の市場規模、シェア、動向分析レポート:包装タイプ別、投与量タイプ別、適応症タイプ別、剤形別、セグメント予測、2023年~2030年Small Volume Parenteral Market Size, Share & Trends Analysis Report By Packaging Type (Ampoules, Vials), By Dose Type (Single-dose, Multiple-dose), By Indication Type (Cancer Care, Diabetes), By Form, And Segment Forecasts, 2023 - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
低用量非経口薬の市場規模、シェア、動向分析レポート:包装タイプ別、投与量タイプ別、適応症タイプ別、剤形別、セグメント予測、2023年~2030年 |
出版日: 2023年09月25日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
|
Grand View Research, Inc.の新しい調査によると、世界の低用量非経口薬市場規模は2030年までに2,985億米ドルに達し、2023年から2030年までのCAGRは7.5%で成長すると予測されています。
低用量非経口薬製剤(SVP)とは、米国薬局方(USP)に記載されているように、100mL未満の溶液を指します。これらの溶液は、必要なときに静脈内投与するように設計されており、通常、注入後6~8時間以内に投与されます。様々な病状や慢性疾患の有病率の増加とSVPの不足が、患者への薬剤や輸液の投与に一般的に使用されるSVP製品の需要を牽引しています。さらに、高齢化社会は、点滴療法を含む医療介入を必要とする様々な健康問題を抱えやすく、SVP製品の需要をさらに高めています。
さらに、政府機関はSVPソリューションの不足を克服するためのイニシアチブを取っています。これは市場成長を促進すると予想されます。例えば、2018年1月、米国医療システム薬剤師会(ASHP)の調査は、米国内の病院内のSVPソリューションの不足のために引き起こされる重大な影響を強調しています。ASHPは、持続的な不足のために引き起こされる公衆衛生の危機に対処するために、主要な利害関係者と協力して政府の関与を結集するためのイニシアチブを開始しました。さらに、COVID-19の大流行は市場の成長に顕著な影響を与えました。
世界中のヘルスケア・システムがウイルスの管理と患者の治療に集中したため、注射薬、輸液、抗生物質などのSVP製品を含む様々な医療用品の需要が増加しました。病院やヘルスケア施設は、特に重篤な状態にある患者の治療をサポートするため、これらの製品の安定供給を維持する必要があっています。この需要の高まりは、SVP製品の生産と販売の増加につながり、業界内のメーカーやサプライヤーに利益をもたらしました。しかし、パンデミックは一時的に市場成長を押し上げたもの、長期的な影響は現在進行中の世界の健康状況やヘルスケアの優先順位のシフトに左右される可能性があることに留意する必要があります。
List of Figure
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 Small Volume Parenteral Market snapshot (2022)
Fig. 11 Small Volume Parenteral Market segmentation
Fig. 12 Market trends and outlook
Fig. 13 Parent market outlook
Fig. 14 Related/ancillary market outlook
Fig. 15 Penetration & growth prospect mapping
Fig. 16 Market driver relevance analysis (Current & future impact)
Fig. 17 Market restraint relevance analysis (Current & future impact)
Fig. 18 Small Volume Parenteral market, form outlook: key takeaways (USD Billion)
Fig. 19 Small Volume Parenteral market: form movement analysis, 2022 & 2030 (USD Billion)
Fig. 20 Dry market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Liquid market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Small Volume Parenteral market, Dose Type outlook: key takeaways (USD Billion)
Fig. 23 Small Volume Parenteral market: Dose Type movement analysis, 2022 & 2030 (USD Billion)
Fig. 24 Single Dose market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 25 Multiple Dose market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 26 Small Volume Parenteral market, Packaging type outlook: key takeaways (USD Billion)
Fig. 27 Small Volume Parenteral market: Packaging movement analysis, 2022 & 2030 (USD Billion)
Fig. 28 Ampoules market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Vials market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 30 Pre-filled Syringes market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 31 Cartridges market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Bottles market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Small Volume Parenteral market, Indication type outlook: key takeaways (USD Billion)
Fig. 35 Small Volume Parenteral market: Indication movement analysis, 2022 & 2030 (USD Billion)
Fig. 36 Pain Management market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Cancer Care market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Malnourishment market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Gastrointestinal disorder/Diarrhea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 Diabetes market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Small Volume Parenteral market, regional marketplace: Key takeaways (USD Billion)
Fig. 43 Small Volume Parenteral market: regional movement analysis, 2021 & 2030 (USD Billion)
Fig. 44 North America Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 U.S. Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Canada Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Europe Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Germany Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 UK Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 France Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Spain Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Italy Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Sweden Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 Denmark Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Norway Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Asia Pacific Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Japan Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 China Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 India Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 Australia Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 South Korea Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 62 Thailand Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Latin America Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 Brazil Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 Mexico Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Argentina Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 67 MEA Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 68 South Africa Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 69 Saudi Arabia Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 70 UAE Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 71 Kuwait Small Volume Parenteral Market estimates and forecasts, 2018 - 2030 (USD Billion)
The global small volume parenteral market size is expected to reach USD 298.5 billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Small-Volume Parenteral (SVPs) refer to solutions containing less than 100 mL, as outlined by the U.S. Pharmacopeia (USP). These solutions are designed for intravenous administration when required, typically within 6-8 hours of infusion. The increasing prevalence of various medical conditions & chronic diseases and the shortage of SVP drive the demand for SVP products commonly used for administering medications and fluids to patients. Moreover, the aging population is prone to various health issues that require medical interventions, including intravenous therapy, further contributing to the demand for SVP products.
In addition, government organizations are taking initiatives to overcome the shortage of SVP solutions. This is expected to propel the market growth. For instance, in January 2018, a survey by the American Society of Health-System Pharmacists (ASHP) underscores the significant impact caused due to the shortages of SVP solutions within hospitals in the U.S. ASHP started the initiative to rally government involvement in collaborating with the major stakeholders to address the public health crisis caused due to the persistent shortages. Moreover, the COVID-19 pandemic has notably impacted the market growth.
As healthcare systems around the world were focused on managing the virus and treating patients, there was an increased demand for various medical supplies, including SVP products like injectable medications, fluids, and antibiotics. Hospitals and healthcare facilities had to maintain a steady supply of these products to support patient care, especially those in critical conditions. This heightened demand led to a rise in the production and sales of SVP products, benefiting manufacturers and suppliers within the industry. However, it's important to note that while the pandemic temporarily boosted market growth, the long-term effects may depend on the ongoing global health situation and shifts in healthcare priorities.